{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:32:57Z","timestamp":1764783177839},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,4,14]],"date-time":"2010-04-14T00:00:00Z","timestamp":1271203200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s00432-010-0882-z","type":"journal-article","created":{"date-parts":[[2010,4,13]],"date-time":"2010-04-13T05:39:22Z","timestamp":1271137162000},"page":"251-259","source":"Crossref","is-referenced-by-count":22,"title":["Peroxisome proliferator-activated receptor-\u03b3 in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival"],"prefix":"10.1007","volume":"137","author":[{"given":"Stamatios","family":"Theocharis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Klijanienko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantinos","family":"Giaginis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Jouffroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelique","family":"Girod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Point","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerasimos","family":"Tsourouflis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Satre-Garau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,14]]},"reference":[{"key":"882_CR1","volume-title":"World Health Organization classifications tumours, pathology and genetics of head and neck tumours","author":"L Barnes","year":"2005","unstructured":"Barnes L, Eveson JW, Reichert P, Sidransky D (2005) World Health Organization classifications tumours, pathology and genetics of head and neck tumours. IARC Press, Lyon"},{"issue":"2","key":"882_CR2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.joms.2005.11.094","volume":"65","author":"RB Bell","year":"2007","unstructured":"Bell RB, Kademani D, Homer L, Dierks EJ, Potter BE (2007) Tongue cancer: is there a difference in survival compared with other subsites in the oral cavity. J Oral Maxillofac Surg 65(2):229\u2013236. doi: 10.1016\/j.joms.2005.11.094","journal-title":"J Oral Maxillofac Surg"},{"issue":"A","key":"882_CR3","first-page":"25","volume":"6","author":"C Blanquicett","year":"2008","unstructured":"Blanquicett C, Roman J, Hart CM (2008) Thiazolidinediones as anti-cancer agents. Cancer Ther 6(A):25\u201334","journal-title":"Cancer Ther"},{"issue":"2","key":"882_CR4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.pas.0000149687.90710.21","volume":"29","author":"M Brandwein-Gensler","year":"2005","unstructured":"Brandwein-Gensler M, Teixeira MS, Lewis CM, Lee B, Rolnitzky JJ, Hille JJ et al (2005) Oral squamous cell carcinoma: histological risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 29(2):167\u2013178","journal-title":"Am J Surg Pathol"},{"issue":"9340","key":"882_CR5","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(02)11199-8","volume":"360","author":"H Brenner","year":"2002","unstructured":"Brenner H (2002) Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 360(9340):1131\u20131135. doi: 10.1016\/S0140-6736(02)11199-8","journal-title":"Lancet"},{"issue":"13","key":"882_CR6","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.4161\/cc.6.13.4453","volume":"6","author":"E Burgermeister","year":"2007","unstructured":"Burgermeister E, Selker R (2007) MAPK kinases as nucleo-cytoplasmic shuttles of PPAR\u03b3. Cell Cycle 6(13):1539\u20132548","journal-title":"Cell Cycle"},{"issue":"8","key":"882_CR7","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.bbalip.2007.04.018","volume":"1771","author":"KA Burns","year":"2007","unstructured":"Burns KA, Vanden Heuvel JP (2007) Modulation of PPAR activity via phosphorylation. Biochim Biophys Acta 1771(8):952\u2013960. doi: 10.1016\/j.bbalip.2007.04.018","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"882_CR8","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S1368-8375(01)00109-9","volume":"38","author":"MT Canto","year":"2002","unstructured":"Canto MT, Devesa SS (2002) Oral cavity and pharynx cancer incidence in the United States, 1975\u20131988. Oral Oncol 38(6):610\u2013617. doi: 10.1016\/S1368-8375(01)00109-9","journal-title":"Oral Oncol"},{"issue":"1","key":"882_CR9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10555-005-5044-4","volume":"24","author":"L D\u00f6brossy","year":"2005","unstructured":"D\u00f6brossy L (2005) Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev 24(1):9\u201317. doi: 10.1007\/s10555-005-5044-4","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"882_CR11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1472-8206.2007.00486.x","volume":"21","author":"C Giaginis","year":"2007","unstructured":"Giaginis C, Tsantili-Kakoulidou A, Theocharis S (2007) Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism. Fundam Clin Pharmacol 21(3):231\u2013244","journal-title":"Fundam Clin Pharmacol"},{"issue":"6","key":"882_CR12","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2174\/156652408785748022","volume":"8","author":"C Giaginis","year":"2008","unstructured":"Giaginis C, Tsourouflis G, Theocharis S (2008a) Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: novel pharmacological agents in the treatment of ischemia reperfusion injury. Curr Mol Med 8(6):562\u2013579","journal-title":"Curr Mol Med"},{"key":"882_CR13","doi-asserted-by":"crossref","first-page":"431763","DOI":"10.1155\/2008\/431763","volume":"2008","author":"C Giaginis","year":"2008","unstructured":"Giaginis C, Tsantili-Kakoulidou A, Theocharis S (2008b) Peroxisome proliferator-activated receptor-gamma ligands: potential pharmacological agents for targeting the angiogenesis signaling cascade in cancer. PPAR Res 2008:431763","journal-title":"PPAR Res"},{"issue":"5","key":"882_CR14","first-page":"BR148","volume":"15","author":"C Giaginis","year":"2009","unstructured":"Giaginis C, Katsamangou E, Tsourouflis G, Zizi-Serbetzoglou D, Kouraklis G, Theocharis S (2009) Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients\u2019 survival. Med Sci Monit 15(5):BR148\u2013156","journal-title":"Med Sci Monit"},{"issue":"1","key":"882_CR17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","volume":"57","author":"A Jemal","year":"2007","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics. CA Cancer J Clin 57(1):43\u201366. doi: 10.3322\/canjclin.57.1.43","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"882_CR18","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00432-009-0602-8","volume":"135","author":"Y Jiang","year":"2009","unstructured":"Jiang Y, Zou L, Zhang C, He S, Cheng C, Xu J et al (2009) PPARgamma and Wnt\/beta-catenin pathway in human breast cancer: expression pattern, molecular interaction and clinical\/prognostic correlations. J Cancer Res Clin Oncol 135(11):1551\u20131559. doi: 10.1007\/s00432-009-0602-8","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"882_CR19","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1054\/bjoc.2000.1323","volume":"83","author":"S Kantola","year":"2000","unstructured":"Kantola S, Parikka M, Jokinen K, Hyrynkangs K, Soini Y, Alho O-P, Salo T (2000) Prognostic factors in tongue cancer-relative importance of demographic, clinical and histopathological factors. Br J Cancer 83(5):614\u2013619. doi: 10.1054\/bjoc.2000.1323","journal-title":"Br J Cancer"},{"issue":"9","key":"882_CR20","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1158\/1078-0432.CCR-06-2062","volume":"13","author":"HJ Kim","year":"2007","unstructured":"Kim HJ, Hwang JY, Kim HJ, Choi WS, Kim HJ, Lee JH et al (2007) Expression of a peroxisome proliferator-activated receptor \u03b31 splice variant that was identified in human lung cancers suppresses cell death induced by cisplatin and oxidative stress. Clin Cancer Res 13(9):2577\u20132583. doi: 10.1158\/1078-0432.CCR-06-2062","journal-title":"Clin Cancer Res"},{"issue":"7","key":"882_CR21","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/1097-0142(19950401)75:7<1649::AID-CNCR2820750715>3.0.CO;2-E","volume":"75","author":"J Klijanienko","year":"1995","unstructured":"Klijanienko J, el-Naggar AK, de Braud F, Rodriguez-Peralto JL, Rodriguez R, Itzhaki M et al (1995) Tumor vascularization, mitotic index, histopathologic grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas. Cancer 75(7):1649\u20131656","journal-title":"Cancer"},{"issue":"7\u20138","key":"882_CR22","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1023\/B:DDAS.0000037790.11724.70","volume":"49","author":"PC Konturek","year":"2004","unstructured":"Konturek PC, Nikiforuk A, Kania J, Raithel M, Hahn EG, M\u00fchldorfer S (2004) Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett\u2019s esophagus: a possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors. Dig Dis Sci 49(7\u20138):1075\u20131083. doi: 10.1023\/B:DDAS.0000037790.11724.70","journal-title":"Dig Dis Sci"},{"issue":"21","key":"882_CR23","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.1158\/1078-0432.CCR-06-0834","volume":"12","author":"G Kristiansen","year":"2006","unstructured":"Kristiansen G, Jacob J, Buckendahl AC, Gr\u00fctzmann R, Alldinger I, Sipos B et al (2006) Peroxisome proliferator-activated receptor gamma is highly expressed in pancreatic cancer and is associated with shorter overall survival times. Clin Cancer Res 12(21):6444\u20136451. doi: 10.1158\/1078-0432.CCR-06-0834","journal-title":"Clin Cancer Res"},{"key":"882_CR24","doi-asserted-by":"crossref","first-page":"134059","DOI":"10.1155\/2008\/134059","volume":"2008","author":"L Michalik","year":"2008","unstructured":"Michalik L, Wahli W (2008) PPARs mediate lipid signaling in inflammation and cancer. PPAR Res 2008:134059. doi: 10.1155\/2008\/134059","journal-title":"PPAR Res"},{"issue":"12","key":"882_CR25","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/01.MP.0000096042.70559.7E","volume":"16","author":"P Mukunyadzi","year":"2003","unstructured":"Mukunyadzi P, Ai L, Portilla D, Barnes EL, Fan CY (2003) Expression of peroxisome proliferator-activated receptor gamma in salivary duct carcinoma: immunohistochemical analysis of 15 cases. Mod Pathol 16(12):1218\u20131223","journal-title":"Mod Pathol"},{"issue":"2","key":"882_CR26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejso.2008.04.003","volume":"35","author":"E Mylona","year":"2009","unstructured":"Mylona E, Giannopoulou I, Diamantopoulou K, Bakarakos P, Nomikos A, Zervas A, Nakopoulou L (2009) Peroxisome proliferator-activated receptor gamma expression in urothelial carcinomas of the bladder: association with differentiation, proliferation and clinical outcome. Eur J Surg Oncol 35(2):197\u2013201. doi: 10.1016\/j.ejso.2008.04.003","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"882_CR27","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/j.gastro.2008.12.048","volume":"136","author":"S Ogino","year":"2009","unstructured":"Ogino S, Shima K, Baba Y, Nosho K, Irahara N, Kure S et al (2009) Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis. Gastroenterology 136(4):1242\u20131250. doi: 10.1053\/j.gastro.2008.12.048","journal-title":"Gastroenterology"},{"issue":"1","key":"882_CR28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1158\/1078-0432.CCR-08-0326","volume":"15","author":"F Ondrey","year":"2009","unstructured":"Ondrey F (2009) Peroxisome proliferator-activated receptor gamma pathway targeting in carcinogenesis: implications for chemoprevention. Clin Cancer Res 15(1):2\u20138. doi: 10.1158\/1078-0432.CCR-08-0326","journal-title":"Clin Cancer Res"},{"issue":"1","key":"882_CR29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2559.2005.02056.x","volume":"46","author":"I Papadaki","year":"2005","unstructured":"Papadaki I, Mylona E, Giannopoulou I, Markaki S, Keramopoulos A, Nakopoulou L (2005) PPAR\u03b3 expression in breast cancer: clinical value and correlation with ER\u03b2. Histopathology 46(1):37\u201342","journal-title":"Histopathology"},{"issue":"1\u20132","key":"882_CR30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1445-2197.2008.04791.x","volume":"79","author":"RS Patel","year":"2009","unstructured":"Patel RS, Clark JR, Dirven R, Wyten R, Gao K, O\u2019Brien CJ (2009) Prognostic factors in the surgical treatment of patients with oral carcinoma. ANZ J Surg 79(1\u20132):19\u201322. doi: 10.1111\/j.1445-2197.2008.04791.x","journal-title":"ANZ J Surg"},{"issue":"2","key":"882_CR31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0002-9610(00)00433-5","volume":"180","author":"A Po Wing Yen","year":"2000","unstructured":"Po Wing Yen A, Lam KY, Wei WI, Lam LK, Ho CM, Chow TL, Yuen WF (2000) A comparison of prognostic significance of tumor diameter, length, width, thickness area, volume and clinicopathological features of oral tongue carcinoma. Am J Surg 180(2):139\u2013143","journal-title":"Am J Surg"},{"issue":"6","key":"882_CR32","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/hed.10094","volume":"24","author":"A Po Wing Yen","year":"2002","unstructured":"Po Wing Yen A, Lam KY, Lam LK, Ho CM, Wong A, Chow TL et al (2002) Prognostic factors clinically stage I and II oral tongue carcinoma: a comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score and pathologic features. Head Neck 24(6):513\u2013520","journal-title":"Head Neck"},{"issue":"1","key":"882_CR33","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1210\/jc.2004-1203","volume":"90","author":"M Sahin","year":"2005","unstructured":"Sahin M, Allard BL, Yates M, Powell JG, Wang XL, Hay ID et al (2005) PPARgamma staining as a surrogate for PAX8\/PPARgamma fusion oncogene expression in follicular neoplasms: clinicopathological correlation and histopathological diagnostic value. J Clin Endocrinol Metab 90(1):463\u2013468. doi: 10.1210\/jc.2004-1203","journal-title":"J Clin Endocrinol Metab"},{"issue":"3\u20134","key":"882_CR34","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10555-007-9082-y","volume":"26","author":"D Sano","year":"2007","unstructured":"Sano D, Myers JN (2007) Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev 26(3\u20134):645\u2013662. doi: 10.1007\/s10555-007-9082-y","journal-title":"Cancer Metastasis Rev"},{"issue":"6","key":"882_CR35","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S1097-2765(01)80012-5","volume":"3","author":"P Sarraf","year":"1999","unstructured":"Sarraf P, Mueller E, Smith WM, Wright HM, Kum JB, Aaltonen LA et al (1999) Loss-of-function mutations in PPAR\u03b3 associated with human colon cancer. Mol Cell 3(6):799\u2013804. doi: 10.1016\/S1097-2765(01)80012-5","journal-title":"Mol Cell"},{"issue":"9","key":"882_CR36","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/cncr.20998","volume":"103","author":"CH Shiboski","year":"2005","unstructured":"Shiboski CH, Schmidt BL, Jordan RC (2005) Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20\u201344\u00a0years. Cancer 103(9):1843\u20131849","journal-title":"Cancer"},{"issue":"6","key":"882_CR37","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000227604","volume":"54","author":"S Shintani","year":"1997","unstructured":"Shintani S, Matsuura H, Hasegawa Y, Nakayama B, Fujimoto Y (1997) The relationship of shape of tumor invasion to depth of invasion and cervical lymph node metastasis in squamous cell carcinoma of the tongue. Oncology 54(6):463\u2013467","journal-title":"Oncology"},{"issue":"9","key":"882_CR38","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1349-7006.2006.00250.x","volume":"97","author":"H Takahashi","year":"2006","unstructured":"Takahashi H, Fujita K, Fujisawa T, Yonemitsu K, Tomimoto A, Ikeda I et al (2006) Inhibition of peroxisome proliferator-activated receptor gamma activity in esophageal carcinoma cells results in a drastic decrease of invasive properties. Cancer Sci 97(9):854\u2013860","journal-title":"Cancer Sci"},{"issue":"3","key":"882_CR39","first-page":"465","volume":"19","author":"T Takashima","year":"2001","unstructured":"Takashima T, Fujiwara Y, Higuchi K, Arakawa T, Yano Y, Hasuma T, Otani S (2001) PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity. Int J Oncol 19(3):465\u2013471","journal-title":"Int J Oncol"},{"issue":"4","key":"882_CR40","first-page":"601","volume":"13","author":"T Takashima","year":"2005","unstructured":"Takashima T, Fujiwara Y, Hamaguchi M, Sasaki E, Tominaga K, Watanabe T et al (2005) Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma. Oncol Rep 13(4):601\u2013606","journal-title":"Oncol Rep"},{"issue":"7","key":"882_CR41","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/jjco\/hyf056","volume":"32","author":"Y Terashita","year":"2002","unstructured":"Terashita Y, Sasaki H, Haruki N, Nishiwaki T, Ishiguro H, Shibata Y et al (2002) Decreased peroxisome proliferator-activated receptor gamma gene expression is correlated with poor prognosis in patients with esophageal cancer. Jpn J Clin Oncol 32(7):238\u2013243","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"882_CR42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0169-5002(02)00013-2","volume":"36","author":"S Theocharis","year":"2002","unstructured":"Theocharis S, Kanelli H, Politi E, Margeli A, Karkandaris C, Philippides T, Koutselinis A (2002) Expression of peroxisome proliferator activated receptor-gamma in non-small cell lung carcinoma: correlation with histological type and grade. Lung Cancer 36(3):249\u2013255","journal-title":"Lung Cancer"},{"issue":"9","key":"882_CR43","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1007\/s10620-007-9794-4","volume":"52","author":"S Theocharis","year":"2007","unstructured":"Theocharis S, Giaginis C, Parasi A, Margeli A, Kakisis J, Agapitos E, Kouraklis G (2007) Expression of peroxisome proliferator-activated receptor-gamma in colon cancer: correlation with histopathological parameters, cell cycle-related molecules, and patients\u2019 survival. Dig Dis Sci 52(9):2305\u20132311","journal-title":"Dig Dis Sci"},{"issue":"1","key":"882_CR44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10555-005-5051-5","volume":"24","author":"J T\u00edm\u00e1r","year":"2005","unstructured":"T\u00edm\u00e1r J, Csuka O, Remen\u00e1r E, R\u00e9p\u00e1ssy G, K\u00e1sler M (2005) Progression of head and neck squamous cell cancer. Cancer Metastasis Rev 24(1):107\u2013127. doi: 10.1007\/s10555-005-5051-5","journal-title":"Cancer Metastasis Rev"},{"issue":"7","key":"882_CR45","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/sj.bjc.6604633","volume":"99","author":"D Wangsa","year":"2008","unstructured":"Wangsa D, Ryott M, Avall-Lundquist E, Petersson F, Elmberg G, Luo J et al (2008) Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma. Br J Cancer 99(7):1121\u20131128. doi: 10.1038\/sj.bjc.6604633","journal-title":"Br J Cancer"},{"issue":"4","key":"882_CR46","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1349-7006.2003.tb01448.x","volume":"94","author":"K Yoshida","year":"2003","unstructured":"Yoshida K, Hirose Y, Tanaka T, Yamada Y, Kuno T, Kohno H et al (2003) Inhibitory effects of troglitazone, a peroxisome proliferator-activated receptor gamma ligand, in rat tongue carcinogenesis initiated with 4-nitroquinoline 1-oxide. Cancer Sci 94(4):365\u2013371","journal-title":"Cancer Sci"},{"issue":"1","key":"882_CR47","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.bjc.6602244","volume":"92","author":"GY Zhang","year":"2005","unstructured":"Zhang GY, Ahmed N, Riley C, Oliva K, Barker G, Quinn MA, Rice GE (2005) Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma. Br J Cancer 92(1):113\u2013119. doi: 10.1038\/sj.bjc.6602244","journal-title":"Br J Cancer"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-010-0882-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-010-0882-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-010-0882-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:39:59Z","timestamp":1559068799000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-010-0882-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,14]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["882"],"URL":"https:\/\/doi.org\/10.1007\/s00432-010-0882-z","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,14]]}}}